A generic alternative indicated for Women's Health. This preparation supports hormonal balance and assists with cycle regulation to promote consistent physiological function.
A progestin hormone intended to manage abnormal uterine bleeding and developed to support menstrual regularity to alleviate symptoms of endometriosis.
Mechanism of Action
It transforms the proliferative endometrium into a secretory one and suppresses the release of pituitary gonadotropins, which prevents ovulation and regulates the cycle.
Route of Administration
Oral
Onset Time
Variable
Duration
24 hours (tablet); 3 months (injection)
Contraindications
History of blood clots, Breast cancer, Liver disease, Pregnancy, Unexplained vaginal bleeding
Severe Adverse Events
Blood clots, Stroke, Liver tumors, Bone density loss (with Depo-Provera)
Information for Medroxyprogesterone is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
